The role of estrogens and estrogen receptors in normal prostate growth and disease
暂无分享,去创建一个
[1] X. Zhang,et al. AP-2 regulates the transcription of estrogen receptor (ER)-β by acting through a methylation hotspot of the 0N promoter in prostate cancer cells , 2007, Oncogene.
[2] S. O. Mueller,et al. Oestrogen receptors pathways to oestrogen responsive elements: The transactivation function-1 acts as the keystone of oestrogen receptor (ER)β-mediated transcriptional repression of ERα , 2007, The Journal of Steroid Biochemistry and Molecular Biology.
[3] A. Koide,et al. Identification of regions within the F domain of the human estrogen receptor alpha that are important for modulating transactivation and protein-protein interactions. , 2007, Molecular endocrinology.
[4] E. Simpson,et al. Essential role for estrogen receptor beta in stromal-epithelial regulation of prostatic hyperplasia. , 2007, Endocrinology.
[5] C. Harwood,et al. Apigenin suppresses cancer cell growth through ERbeta. , 2006, Neoplasia.
[6] G. Prins,et al. The Role of Estrogens in Normal and Abnormal Development of the Prostate Gland , 2006, Annals of the New York Academy of Sciences.
[7] S. Ho,et al. Estrogen receptor (ER)-β isoforms: A key to understanding ER-β signaling , 2006, Proceedings of the National Academy of Sciences.
[8] Shuk-Mei Ho,et al. 4 Epigenetically Regulates Phosphodiesterase Type 4 Variant Increases Susceptibility to Prostate Carcinogenesis and Developmental Exposure to Estradiol and Bisphenol A , 2006 .
[9] G. Risbridger,et al. Aromatase and prostate cancer. , 2006, Minerva endocrinologica.
[10] I. Thompson,et al. Association between an estrogen receptor alpha gene polymorphism and the risk of prostate cancer in black men. , 2006, The Journal of urology.
[11] T. Slaga,et al. 2-Methoxyestradiol Inhibits Prostate Tumor Development in Transgenic Adenocarcinoma of Mouse Prostate: Role of Tumor Necrosis Factor-α–Stimulated Gene 6 , 2006, Clinical Cancer Research.
[12] Hong-ying Huang,et al. IMMUNOLOCALIZATION OF ESTROGEN RECEPTOR AND IN HUMAN FETAL PROSTATE , 2005 .
[13] J. Kaufman,et al. The decline of androgen levels in elderly men and its clinical and therapeutic implications. , 2005, Endocrine reviews.
[14] B. Katzenellenbogen,et al. The androgen derivative 5alpha-androstane-3beta,17beta-diol inhibits prostate cancer cell migration through activation of the estrogen receptor beta subtype. , 2005, Cancer research.
[15] C. Lamartiniere,et al. Dietary genistein improves survival and reduces expression of osteopontin in the prostate of transgenic mice with prostatic adenocarcinoma (TRAMP). , 2005, The Journal of nutrition.
[16] J. Brooks,et al. Resveratrol-Induced Gene Expression Profiles in Human Prostate Cancer Cells , 2005, Cancer Epidemiology Biomarkers & Prevention.
[17] E. Giovannucci,et al. The epidemiology of sex steroid hormones and their signaling and metabolic pathways in the etiology of prostate cancer , 2004, The Journal of Steroid Biochemistry and Molecular Biology.
[18] G. N. Sastry,et al. Aromatase inhibitors: a new paradigm in breast cancer treatment. , 2004, Current medicinal chemistry. Anti-cancer agents.
[19] Ruth Etzioni,et al. Metastases of prostate cancer express estrogen receptor-beta. , 2004, Urology.
[20] J. Gustafsson,et al. Estrogen Receptor-Beta Regulates Epithelial Cell Differentiation in the Mouse Ventral Prostate , 2004, Hormone Research in Paediatrics.
[21] J. Gustafsson,et al. Estrogen receptor β regulates epithelial cellular differentiation in the mouse ventral prostate , 2004 .
[22] F. Domann,et al. Flipping the epigenetic switch. , 2004, The American journal of pathology.
[23] I. Leav,et al. Dynamic regulation of estrogen receptor-beta expression by DNA methylation during prostate cancer development and metastasis. , 2004, The American journal of pathology.
[24] E. J. Lee,et al. Expression of estrogen receptor β in prostate carcinoma cells inhibits invasion and proliferation and triggers apoptosis , 2004, FEBS letters.
[25] J. F. Schmitt,et al. Local aromatase expression in human prostate is altered in malignancy. , 2004, The Journal of clinical endocrinology and metabolism.
[26] S. Ho. Estrogens and anti‐estrogens: Key mediators of prostate carcinogenesis and new therapeutic candidates , 2004, Journal of cellular biochemistry.
[27] T. Miki,et al. Serum phytoestrogens and prostate cancer risk in a nested case‐control study among Japanese men , 2004, Cancer science.
[28] B. Komm,et al. Evaluation of an Estrogen Receptor-β Agonist in Animal Models of Human Disease , 2003 .
[29] David C. Jones,et al. The selective estrogen receptor modulator trioxifene (LY133314) inhibits metastasis and extends survival in the PAIII rat prostatic carcinoma model. , 2003, Cancer research.
[30] R. Dahiya,et al. Polymorphisms of estrogen receptor alpha in prostate cancer , 2003, Molecular carcinogenesis.
[31] S. Gomez,et al. Soy and isoflavone consumption in relation to prostate cancer risk in China. , 2003, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.
[32] N. Fujimoto,et al. Regulation of estrogen receptor alpha and beta expression by testosterone in the rat prostate gland. , 2003, Endocrine journal.
[33] M. Steiner,et al. Phase IIA clinical trial to test the efficacy and safety of Toremifene in men with high-grade prostatic intraepithelial neoplasia. , 2003, Clinical prostate cancer.
[34] G. Prins,et al. The role of prolactin in the prostatic inflammatory response to neonatal estrogen. , 2003, Endocrinology.
[35] Brad Saville,et al. Domains of Estrogen Receptor α (ERα) Required for ERα/Sp1-Mediated Activation of GC-Rich Promoters by Estrogens and Antiestrogens in Breast Cancer Cells , 2003 .
[36] H. Bonkhoff,et al. Differential expression of the estrogen receptor beta (ERβ) in human prostate tissue, premalignant changes, and in primary, metastatic, and recurrent prostatic adenocarcinoma , 2003, The Prostate.
[37] Jun Wang,et al. Dietary genistein suppresses chemically induced prostate cancer in Lobund-Wistar rats. , 2002, Cancer letters.
[38] J. Manola,et al. Selective aromatase inhibition for patients with androgen‐independent prostate carcinoma , 2002, Cancer.
[39] B. Katzenellenbogen,et al. Characterization of the Biological Roles of the Estrogen Receptors, ERα and ERβ, in Estrogen Target Tissues in Vivo through the Use of an ERα-Selective Ligand , 2002 .
[40] Seong-Jin Kim,et al. Raloxifene, a mixed estrogen agonist/antagonist, induces apoptosis in androgen-independent human prostate cancer cell lines. , 2002, Cancer research.
[41] J. Gustafsson,et al. Estrogen receptor beta in the prostate , 2002, Molecular and Cellular Endocrinology.
[42] I. Leav,et al. Expression of estrogen receptor beta in the fetal, neonatal, and prepubertal human prostate , 2002, The Prostate.
[43] David A. Agard,et al. Structural characterization of a subtype-selective ligand reveals a novel mode of estrogen receptor antagonism , 2002, Nature Structural Biology.
[44] R. Vessella,et al. Inhibition of androgen-independent growth of prostate cancer xenografts by 17beta-estradiol. , 2002, Clinical cancer research : an official journal of the American Association for Cancer Research.
[45] H. Harris,et al. The ligand binding profiles of estrogen receptors α and β are species dependent , 2002, Steroids.
[46] K. Korach,et al. Requirement of Estrogen Receptor-α in Insulin-like Growth Factor-1 (IGF-1)-induced Uterine Responses and in Vivo Evidence for IGF-1/Estrogen Receptor Cross-talk* , 2002, The Journal of Biological Chemistry.
[47] N. Bruchovsky,et al. Activation of the Androgen Receptor N-terminal Domain by Interleukin-6 via MAPK and STAT3 Signal Transduction Pathways* , 2002, The Journal of Biological Chemistry.
[48] M. Steiner,et al. Toremifene prevents prostate cancer in the transgenic adenocarcinoma of mouse prostate model. , 2002, Cancer research.
[49] J. Kaufman,et al. Estradiol in elderly men , 2002, The aging male : the official journal of the International Society for the Study of the Aging Male.
[50] Y. Ouchi,et al. Differential Expression of Estrogen Receptor β (ERβ) and Its C-Terminal Truncated Splice Variant ERβcx as Prognostic Predictors in Human Prostatic Cancer , 2001 .
[51] D. Theodorescu,et al. Use of the aromatase inhibitor anastrozole in the treatment of patients with advanced prostate carcinoma , 2001, Cancer.
[52] S. Cl,et al. Intracellular signaling pathways: nongenomic actions of estrogens and ligand-independent activation of estrogen receptors. , 2001 .
[53] B. Katzenellenbogen,et al. Estrogen Imprinting of the Developing Prostate Gland Is Mediated through Stromal Estrogen Receptor α Studies with αERKO and βERKO Mice , 2001 .
[54] J. Gustafsson,et al. Frequent Loss of Estrogen Receptor-β Expression in Prostate Cancer , 2001 .
[55] I. Leav,et al. Comparative Studies of the Estrogen Receptors β and α and the Androgen Receptor in Normal Human Prostate Glands, Dysplasia, and in Primary and Metastatic Carcinoma , 2001 .
[56] Á. Pascual,et al. Nuclear hormone receptors and gene expression. , 2001, Physiological reviews.
[57] R. Mcmurray,et al. Estrogen, prolactin, and autoimmunity: actions and interactions. , 2001, International immunopharmacology.
[58] S. Stein,et al. Phase II Trial of Toremifene in Androgen‐Independent Prostate Cancer: A Penn Cancer Clinical Trials Group Trial , 2001, American journal of clinical oncology.
[59] J. McLachlan,et al. Environmental signaling: what embryos and evolution teach us about endocrine disrupting chemicals. , 2001, Endocrine reviews.
[60] L. Andersson,et al. A role for estrogen receptor β in the regulation of growth of the ventral prostate , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[61] J. Gustafsson,et al. Evidence that epithelial and mesenchymal estrogen receptor-alpha mediates effects of estrogen on prostatic epithelium. , 2001, Developmental biology.
[62] J. Gustafsson,et al. Erratum: Differential expression of estrogen receptors α and β in adult rat accessory sex glands and lower urinary tract (Molecular and Cellular Endocrinology 164 (2000) (109-116) PII: S0303720700002331) , 2000 .
[63] B. Katzenellenbogen,et al. Estrogen receptors: selective ligands, partners, and distinctive pharmacology. , 2000, Recent progress in hormone research.
[64] D. Agard,et al. Estrogen receptor pathways to AP-1 , 2000, The Journal of Steroid Biochemistry and Molecular Biology.
[65] K. Korach,et al. Receptor null mice reveal contrasting roles for estrogen receptor α and β in reproductive tissues , 2000, The Journal of Steroid Biochemistry and Molecular Biology.
[66] P. Chambon,et al. Effect of single and compound knockouts of estrogen receptors alpha (ERalpha) and beta (ERbeta) on mouse reproductive phenotypes. , 2000, Development.
[67] G. Prins,et al. Evidence that estrogens directly alter androgen-regulated prostate development. , 2000, Endocrinology.
[68] J. Gustafsson,et al. Functional Differences between the Amino-Terminal Domains of Estrogen Receptors α and β , 2000 .
[69] J. Gustafsson,et al. Differential expression of estrogen receptors α and β in adult rat accessory sex glands and lower urinary tract , 2000, Molecular and Cellular Endocrinology.
[70] S. Ho,et al. Expression of estrogen receptor (ER)-alpha and ER-beta in normal and malignant prostatic epithelial cells: regulation by methylation and involvement in growth regulation. , 2000, Cancer research.
[71] K. Tung,et al. Normal development of thymus in male and female mice requires estrogen/estrogen receptor-α signaling pathway , 2000, Endocrine.
[72] H. Adami,et al. Duration of gestation and prostate cancer risk in offspring. , 2000, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.
[73] R. Dahiya,et al. Frequent methylation of estrogen receptor in prostate cancer: correlation with tumor progression. , 2000, Cancer research.
[74] M. Martin,et al. Regulation of estrogen receptor‐α gene expression by 1,25‐dihydroxyvitamin D in MCF‐7 cells , 1999 .
[75] J. Epstein,et al. Proliferative inflammatory atrophy of the prostate: implications for prostatic carcinogenesis. , 1999, The American journal of pathology.
[76] S. Steinberg,et al. A Phase II study of high-dose tamoxifen in patients with hormone-refractory prostate cancer. , 1999, Clinical cancer research : an official journal of the American Association for Cancer Research.
[77] H. Bonkhoff,et al. Estrogen receptor expression in prostate cancer and premalignant prostatic lesions. , 1999, The American journal of pathology.
[78] G. Prins,et al. Estrogen receptor‐β: Implications for the prostate gland , 1999 .
[79] K. Umesono,et al. A Unified Nomenclature System for the Nuclear Receptor Superfamily , 1999, Cell.
[80] S. Cowley,et al. A comparison of transcriptional activation by ERα and ERβ , 1999, The Journal of Steroid Biochemistry and Molecular Biology.
[81] J. Corton,et al. Interaction of Estrogenic Chemicals and Phytoestrogens with Estrogen Receptor β. , 1998, Endocrinology.
[82] Anil K. Jaiswal,et al. Transcriptional Regulation of the Human Quinone Reductase Gene by Antiestrogen-liganded Estrogen Receptor-α and Estrogen Receptor-β* , 1998, The Journal of Biological Chemistry.
[83] S. Kato,et al. A novel isoform of rat estrogen receptor beta with 18 amino acid insertion in the ligand binding domain as a putative dominant negative regular of estrogen action. , 1998, Biochemical and biophysical research communications.
[84] P. Koza-Taylor,et al. Identification of Estrogen Receptor β2, A Functional Variant of Estrogen Receptor β Expressed in Normal Rat Tissues. , 1998, Endocrinology.
[85] J. Gustafsson,et al. Human estrogen receptor beta-gene structure, chromosomal localization, and expression pattern. , 1997, The Journal of clinical endocrinology and metabolism.
[86] Eva Enmark,et al. Journal of Clinical Endocrinology and Metabolism Printed in U.S.A. Copyright © 1997 by The Endocrine Society Human Estrogen Receptor �-Gene Structure, Chromosomal Localization, and Expression Pattern* , 2022 .
[87] W. Rand,et al. Suppression of testosterone and estradiol-17beta-induced dysplasia in the dorsolateral prostate of Noble rats by bromocriptine. , 1997, Carcinogenesis.
[88] S. Inoue,et al. Agonistic effect of tamoxifen is dependent on cell type, ERE-promoter context, and estrogen receptor subtype: functional difference between estrogen receptors alpha and beta. , 1997, Biochemical and biophysical research communications.
[89] J. Gustafsson,et al. The novel estrogen receptor‐β subtype: potential role in the cell‐ and promoter‐specific actions of estrogens and anti‐estrogens , 1997, FEBS letters.
[90] G. Prins,et al. Neonatal estrogen exposure up-regulates estrogen receptor expression in the developing and adult rat prostate lobes. , 1997, Endocrinology.
[91] B. Gladen,et al. Targeted disruption of the estrogen receptor gene in male mice causes alteration of spermatogenesis and infertility. , 1996, Endocrinology.
[92] V. James. Non-reproductive actions of sex steroids , 1996, British Journal of Cancer.
[93] T. H. van der Kwast,et al. Elevated estrogen receptor expression in human prostatic stromal cells by androgen ablation therapy. , 1996, The Journal of urology.
[94] J. Polman,et al. ERβ: Identification and characterization of a novel human estrogen receptor , 1996 .
[95] H. Adami,et al. Perinatal characteristics in relation to incidence of and mortality from prostate cancer , 1996, BMJ.
[96] J. Gustafsson,et al. Cloning of a novel receptor expressed in rat prostate and ovary. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[97] K. Korach,et al. Morphometric study of the gubernaculum in male estrogen receptor mutant mice. , 1996, Journal of andrology.
[98] K. Umesono,et al. The nuclear receptor superfamily: The second decade , 1995, Cell.
[99] B. Katzenellenbogen,et al. The carboxy-terminal F domain of the human estrogen receptor: role in the transcriptional activity of the receptor and the effectiveness of antiestrogens as estrogen antagonists. , 1995, Molecular endocrinology.
[100] Elizabeth Hatch,et al. Diethylstilbestrol Revisited: A Review of the Long-Term Health Effects , 1995, Annals of Internal Medicine.
[101] R. Miksicek. Steroid receptor variants and their potential role in cancer. , 1994, Seminars in cancer biology.
[102] J. A. Thomas,et al. Effects of estrogens on the prostate. , 1994, Journal of andrology.
[103] M. Nevalainen,et al. Hormone regulation of human prostate in organ culture. , 1993, Cancer research.
[104] G. Prins. Neonatal estrogen exposure induces lobe-specific alterations in adult rat prostate androgen receptor expression. , 1992, Endocrinology.
[105] K. Korach,et al. Coupling of dual signaling pathways: epidermal growth factor action involves the estrogen receptor. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[106] I. Leav,et al. Biochemical alterations in sex hormone-induced hyperplasia and dysplasia of the dorsolateral prostates of Noble rats. , 1988, Journal of the National Cancer Institute.
[107] H. Bauer,et al. Evaluation of the cytotoxic activity of diethylstilbestrol and its mono- and diphosphate towards prostatic carcinoma cells. , 1988, Cancer research.
[108] B. Henderson,et al. The early in utero oestrogen and testosterone environment of blacks and whites: potential effects on male offspring. , 1988, British Journal of Cancer.
[109] E. Barrack,et al. Immunocytochemical localization of estrogen receptors in the normal male and female canine urinary tract and prostate. , 1987, Endocrinology.
[110] J. Ham,et al. Structural organization and expression of the mouse estrogen receptor. , 1987, Molecular endocrinology.
[111] D W Nebert,et al. The P450 gene superfamily: recommended nomenclature. , 1987, DNA.
[112] S. Attree,et al. Hormone levels in the foetal and neonatal prostate. , 1986, Acta endocrinologica.
[113] P. Chambon,et al. Cloning of the human estrogen receptor cDNA. , 1985, Proceedings of the National Academy of Sciences of the United States of America.
[114] G. Prins,et al. Effect of Estradiol on the Rat Prostate in the Presence and Absence of Testosterone and Pituitary , 1981 .
[115] M. Krieg,et al. Stroma of human benign prostatic hyperplasia: preferential tissue for androgen metabolism and oestrogen binding. , 1981, Acta endocrinologica.
[116] S. Taylor,et al. Effects of Prenatal Maternal Estrogen on the Male Urogenital System , 1980, Obstetrics and gynecology.
[117] P. Walsh,et al. Comparison of spontaneous and experimentally induced canine prostatic hyperplasia. , 1979, The Journal of clinical investigation.
[118] D. S. Coffey,et al. Sex steroid imprinting of the immature prostate. Long-term effects. , 1978, Investigative urology.
[119] C. Huggins,et al. Studies on prostatic cancer. I. The effect of castration, of estrogen and androgen injection on serum phosphatases in metastatic carcinoma of the prostate. , 1941, CA: a cancer journal for clinicians.
[120] D. Price. Normal development of the prostate and seminal vesicles of the rat with a study of experimental postnatal modifications , 1936 .
[121] Sidney Glina,et al. Studies on Prostatic Cancer I. The Effect of Castration, of Estrogen and of Androgen Injection on Serum Phosphatases in , 2010 .
[122] S. Ho,et al. Estrogen receptor (ER)-beta isoforms: a key to understanding ER-beta signaling. , 2006, Proceedings of the National Academy of Sciences of the United States of America.
[123] S. Assinder,et al. Effect of increasing ratio of estrogen: Androgen on proliferation of normal human prostate stromal and epithelial cells, and the malignant cell line LNCaP , 2006, The Prostate.
[124] C. Harwood,et al. Apigenin suppresses cancer cell growth through ERbeta. , 2006, Neoplasia.
[125] Hong-ying Huang,et al. Immunolocalization of estrogen receptor alpha and beta in human fetal prostate. , 2005, The Journal of urology.
[126] A. Gescher,et al. Innovative agents in cancer prevention. , 2005, Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer.
[127] S. Safe,et al. Nuclear receptor-mediated transactivation through interaction with Sp proteins. , 2004, Progress in nucleic acid research and molecular biology.
[128] T. DeWeese,et al. The Diet, Prostate Inflammation, and the Development of Prostate Cancer , 2004, Cancer and Metastasis Reviews.
[129] J. J. Bianco,et al. International Congress on Hormonal Steroids and Hormones and Cancer Oestrogens and prostate cancer , 2003 .
[130] Brad Saville,et al. Domains of estrogen receptor alpha (ERalpha) required for ERalpha/Sp1-mediated activation of GC-rich promoters by estrogens and antiestrogens in breast cancer cells. , 2003, Molecular endocrinology.
[131] B. Komm,et al. Evaluation of an estrogen receptor-beta agonist in animal models of human disease. , 2003, Endocrinology.
[132] Vincent Laudet,et al. The nuclear receptor factsbook , 2002 .
[133] B. Katzenellenbogen,et al. Characterization of the biological roles of the estrogen receptors, ERalpha and ERbeta, in estrogen target tissues in vivo through the use of an ERalpha-selective ligand. , 2002, Endocrinology.
[134] H. Harris,et al. The ligand binding profiles of estrogen receptors alpha and beta are species dependent. , 2002, Steroids.
[135] V. Rossi,et al. Loss of estrogen receptor beta expression in malignant human prostate cells in primary cultures and in prostate cancer tissues. , 2001, The Journal of clinical endocrinology and metabolism.
[136] J. Gustafsson,et al. Frequent loss of estrogen receptor-beta expression in prostate cancer. , 2001, Cancer research.
[137] Carolyn L. Smith,et al. Intracellular signaling pathways: nongenomic actions of estrogens and ligand-independent activation of estrogen receptors. , 2001, Frontiers in bioscience : a journal and virtual library.
[138] Y. Ouchi,et al. Differential expression of estrogen receptor beta (ERbeta) and its C-terminal truncated splice variant ERbetacx as prognostic predictors in human prostatic cancer. , 2001, Biochemical and biophysical research communications.
[139] I. Leav,et al. Comparative studies of the estrogen receptors beta and alpha and the androgen receptor in normal human prostate glands, dysplasia, and in primary and metastatic carcinoma. , 2001, The American journal of pathology.
[140] J. Gustafsson,et al. Differential expression of estrogen receptors alpha and beta in adult rat accessory sex glands and lower urinary tract. , 2000, Molecular and cellular endocrinology.
[141] K. Korach,et al. Activation of a uterine insulin-like growth factor I signaling pathway by clinical and environmental estrogens: requirement of estrogen receptor-alpha. , 2000, Endocrinology.
[142] K. Korach,et al. Receptor null mice reveal contrasting roles for estrogen receptor alpha and beta in reproductive tissues. , 2000, The Journal of steroid biochemistry and molecular biology.
[143] M. Yancisin,et al. Functional analysis of a novel estrogen receptor-beta isoform. , 1999, Molecular endocrinology.
[144] S. Cowley,et al. A comparison of transcriptional activation by ER alpha and ER beta. , 1999, The Journal of steroid biochemistry and molecular biology.
[145] M. Shaalan. Effects of estrogen on the Prostate and Seminal vesicles of the Castrated Guinea Pig .microanatomical Study , 1998 .
[146] P. Koza-Taylor,et al. Identification of estrogen receptor beta2, a functional variant of estrogen receptor beta expressed in normal rat tissues. , 1998, Endocrinology.
[147] R. Naz. Prostate : basic and clinical aspects , 1997 .
[148] K. Grandien,et al. Comparison of the Ligand Binding Specificity and Transcript Tissue Distribution of Estrogen Receptors a and b , 1997 .
[149] J. Polman,et al. ER beta: identification and characterization of a novel human estrogen receptor. , 1996, FEBS letters.
[150] G. Carruba,et al. Human prostate cancer: a direct role for oestrogens. , 1995, Ciba Foundation symposium.
[151] M. Sluyser. Mutations in the estrogen receptor gene , 1995, Human mutation.
[152] G. Bock,et al. Non-reproductive actions of sex steroids , 1995 .
[153] S. Mée,et al. Temporal and spatial factors in diethylstilbestrol-induced squamous metaplasia in the developing human prostate. II. Persistent changes after removal of diethylstilbestrol. , 1995, Acta anatomica.
[154] M. Soloway,et al. Immunohistochemical evidence of the existence and localization of aromatase in human prostatic tissues , 1992, The Prostate.
[155] R. Bosch,et al. Pathogenesis of benign prostatic hyperplasia. , 1991, European urology.
[156] H. Schulze,et al. Histological localization of estrogen receptors in normal and diseased human prostates by immunocytochemistry , 1990, The Prostate.
[157] P. Heitz,et al. Morphological and immunohistochemical investigations of the utriculus prostaticus from the fetal period up to adulthood , 1990, The Prostate.
[158] P. Walsh,et al. Clinical and experimental studies of benign prostatic hyperplasia. , 1990, The Urologic clinics of North America.
[159] R. Brenner,et al. Estrogen and progestin receptors in the reproductive tract of male and female primates. , 1990, Biology of reproduction.
[160] D. Horsfall,et al. Effect of pubertal development on estrogen receptor levels and stromal morphology in the guinea pig prostate , 1989, The Prostate.
[161] D. Horsfall,et al. Effects of ageing and hormonal manipulations on the level of oestrogen receptors in the guinea-pig prostate. , 1987, The Journal of endocrinology.
[162] H. Bern,et al. Long-term effects of perinatal exposure to sex steroids and diethylstilbestrol on the reproductive system of male mammals. , 1983, International review of cytology.
[163] M. Krieg,et al. Nuclei of stroma: Site of highest estrogen concentration in human benign prostatic hyperplasia , 1982, The Prostate.
[164] J. Gustafsson,et al. Cloning of a novel estrogen receptor expressed in rat prostate and ovary , 2022 .
[165] S. Inoue,et al. Zone-Dependent Expression of Estrogen Receptors and in Human Benign Prostatic Hyperplasia , 2003 .
[166] G. Prins,et al. Estrogen Receptor-b Messenger Ribonucleic Acid Ontogeny in the Prostate of Normal and Neonatally Estrogenized Rats , 1998 .